BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17208640)

  • 1. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.
    Wilcken B; Haas M; Joy P; Wiley V; Chaplin M; Black C; Fletcher J; McGill J; Boneh A
    Lancet; 2007 Jan; 369(9555):37-42. PubMed ID: 17208640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome.
    Joy P; Black C; Rocca A; Haas M; Wilcken B
    Child Neuropsychol; 2009 Jan; 15(1):8-20. PubMed ID: 18608229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening.
    Haas M; Chaplin M; Joy P; Wiley V; Black C; Wilcken B
    J Pediatr; 2007 Aug; 151(2):121-6, 126.e1. PubMed ID: 17643760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
    van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM
    J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Anderson DR; Viau K; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2020 Jan; 129(1):13-19. PubMed ID: 31836396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada.
    Karaceper MD; Khangura SD; Wilson K; Coyle D; Brownell M; Davies C; Dodds L; Feigenbaum A; Fell DB; Grosse SD; Guttmann A; Hawken S; Hayeems RZ; Kronick JB; Laberge AM; Little J; Mhanni A; Mitchell JJ; Nakhla M; Potter M; Prasad C; Rockman-Greenberg C; Sparkes R; Stockler S; Ueda K; Vallance H; Wilson BJ; Chakraborty P; Potter BK;
    Orphanet J Rare Dis; 2019 Mar; 14(1):70. PubMed ID: 30902101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis.
    Wilson CJ; Champion MP; Collins JE; Clayton PT; Leonard JV
    Arch Dis Child; 1999 May; 80(5):459-62. PubMed ID: 10208954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.
    Derks TG; Boer TS; van Assen A; Bos T; Ruiter J; Waterham HR; Niezen-Koning KE; Wanders RJ; Rondeel JM; Loeber JG; Ten Kate LP; Smit GP; Reijngoud DJ
    J Inherit Metab Dis; 2008 Feb; 31(1):88-96. PubMed ID: 18188679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
    Hsu HW; Zytkovicz TH; Comeau AM; Strauss AW; Marsden D; Shih VE; Grady GF; Eaton RB
    Pediatrics; 2008 May; 121(5):e1108-14. PubMed ID: 18450854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for inherited metabolic disease.
    Grosse SD; Dezateux C
    Lancet; 2007 Jan; 369(9555):5-6. PubMed ID: 17208621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].
    Feillet F; Ogier H; Cheillan D; Aquaviva C; Labarthe F; Baruteau J; Chabrol B; de Lonlay P; Valayanopoulos V; Garnotel R; Dobbelaere D; Briand G; Jeannesson E; Vassault A; Vianey-Saban C;
    Arch Pediatr; 2012 Feb; 19(2):184-93. PubMed ID: 22244319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening.
    Nennstiel-Ratzel U; Arenz S; Maier EM; Knerr I; Baumkötter J; Röschinger W; Liebl B; Hadorn HB; Roscher AA; von Kries R
    Mol Genet Metab; 2005 Jun; 85(2):157-9. PubMed ID: 15896661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.
    Rhead WJ
    J Inherit Metab Dis; 2006; 29(2-3):370-7. PubMed ID: 16763904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
    Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
    Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
    Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome.
    Derks TG; Reijngoud DJ; Waterham HR; Gerver WJ; van den Berg MP; Sauer PJ; Smit GP
    J Pediatr; 2006 May; 148(5):665-670. PubMed ID: 16737882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-chain acyl-CoA dehydrogenase deficiency: genotype-biochemical phenotype correlations.
    Waddell L; Wiley V; Carpenter K; Bennetts B; Angel L; Andresen BS; Wilcken B
    Mol Genet Metab; 2006 Jan; 87(1):32-9. PubMed ID: 16291504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.
    Horvath GA; Davidson AG; Stockler-Ipsiroglu SG; Lillquist YP; Waters PJ; Olpin S; Andresen BS; Palaty J; Nelson J; Vallance H
    Can J Public Health; 2008; 99(4):276-80. PubMed ID: 18767270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies.
    Ziadeh R; Hoffman EP; Finegold DN; Hoop RC; Brackett JC; Strauss AW; Naylor EW
    Pediatr Res; 1995 May; 37(5):675-8. PubMed ID: 7603790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.